Featured Research

from universities, journals, and other organizations

Laser Therapies For Hair Removal Appear To Be More Effective Than Combination Treatments, Study Suggests

Date:
October 25, 2008
Source:
JAMA and Archives Journals
Summary:
Laser therapies commonly used for removal of unwanted hair appear to be safer and remove leg hair more effectively when used separately than when used as a combination treatment, according to a new report.

Laser therapies commonly used for removal of unwanted hair appear to be safer and remove leg hair more effectively when used separately than when used as a combination treatment, according to a new report.

"Unwanted hair that potentially has profound effects on psychological well-being is an exceedingly common concern for men and women," according to background information in the article. During the past decade, laser hair removal has become a popular and accepted method used to reduce the growth of unwanted hair. "Laser-assisted photoepilation or laser hair removal, as first reported in 1996, is accomplished through destruction of the follicular unit [the hair follicle]."

Seyyed Masoud Davoudi, M.D., of the Baqiyatallah University of Medical Sciences, Tehran, Iran, and colleagues analyzed the results of using long-pulsed 755-nanometer alexandrite lasers (12-millimeter and 18-millimeter spot sizes) individually, using a long-pulsed 1,064-nanometer Nd:YAG laser (12-millimeter spot size) and using a combination of the Nd:YAG and alexandrite 12-millimeter spot lasers to reduce leg hair growth on four areas of the legs of 20 individuals (average age 32.6). Participants underwent treatment at a private laser skin center and received a total of four treatment sessions at eight-week intervals, and 15 patients completed the study. Average hair density was measured with a hair counting device and special software (Visionmed AG) and hair reduction was assessed through digital photographs before treatment and at eight- and 18-month follow up sessions. Adverse effects following treatment were also noted.

The average hair reductions 18 months after final treatment were 75.9 percent for the 12-millimeter spot size alexandrite laser, 84.3 percent for the 18-millimeter spot size alexandrite laser, 73.6 percent for the Nd:YAG laser and 77.8 percent for the combination therapy.

Average pain severity was higher in areas that received the alexandrite laser treatments than in those treated with the Nd:YAG laser. Additionally, the highest incidence of pain was reported in areas that received the combination treatment. Areas with combination treatment were also more likely to experience hyperpigmentation (dark spots on the skin), with four participants experiencing this complication until the last follow-up session.

"Despite other studies showing more efficacy of the alexandrite rather than the Nd:YAG laser, our trial results showed no significant difference between them," the authors conclude. "The use of alexandrite or Nd:YAG laser systems alone for at least four treatments sessions and with eight-week intervals have long-term persistent efficacy in hair reduction with acceptable and transient adverse effects."

This was supported by a research grant from the Undersecretary of Research, Tehran University of Medical Sciences.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Seyyed Masoud Davoudi; Fereydoun Behnia; Farzam Gorouhi; Saeed Keshavarz; Mansour Nassiri Kashani; Mehdi Rashighi Firoozabadi; Alireza Firooz. Comparison of Long-Pulsed Alexandrite and Nd:YAG Lasers, Individually and in Combination, for Leg Hair Reduction. Arch Dermatol., 2008;144(10):1323-1327 [link]

Cite This Page:

JAMA and Archives Journals. "Laser Therapies For Hair Removal Appear To Be More Effective Than Combination Treatments, Study Suggests." ScienceDaily. ScienceDaily, 25 October 2008. <www.sciencedaily.com/releases/2008/10/081020171237.htm>.
JAMA and Archives Journals. (2008, October 25). Laser Therapies For Hair Removal Appear To Be More Effective Than Combination Treatments, Study Suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/10/081020171237.htm
JAMA and Archives Journals. "Laser Therapies For Hair Removal Appear To Be More Effective Than Combination Treatments, Study Suggests." ScienceDaily. www.sciencedaily.com/releases/2008/10/081020171237.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins